Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO
Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO Rhea-AI Filing Summary Vivani Medical, Inc. granted Chief Business Officer Donald Dwyer equity awards consisting of stock options and performance-based RSUs. He received 70000.0000 common stock options with a 10-year term and a 1.3100 exercise price, vesting 25% after one year and monthly over 36 months, subject to continued service.
How this was made
The 30-second read
Why it matters
For traders, the main actionable element is the $3.15 performance threshold and multi-stage vesting, which can affect insider alignment narratives but typically does not change fundamentals immediately.
Market read
This is a primary disclosure of equity-compensation terms, not a financial result, guidance change, or deal.
What to watch
The article does not state total compensation cost, dilution impact, or whether similar grants have been made recently, limiting inference about future share supply.
Background
The piece summarizes equity awards granted to Vivani’s Chief Business Officer, including option vesting and performance-based RSU conditions.
Ticker impact
Vivani granted its Chief Business Officer 70,000 options and 35,000 performance-based RSUs with a $3.15 stock-price vesting condition.
Low likelihood of a sustained price move solely from this grant; any reaction is likely muted.
The article provides Form 4-style grant terms (options, RSUs, vesting schedule, $3.15 condition) but no new operational, financial, or regulatory catalyst.
Market effects
Minimal sector read-through; equity-compensation terms are company-specific.
None indicated.
None indicated.
Counterpoint
Performance-based RSUs tied to $3.15 could be interpreted as management signaling confidence in a higher stock price, but the grant size is unlikely to drive valuation.
Key entities
- companyVivani Medical, Inc.
Subject of the equity-award disclosure to its Chief Business Officer.
- insiderDonald Dwyer
Chief Business Officer receiving 70,000 options and 35,000 performance-based RSUs.
